KalVista Pharmaceuticals (KALV) Net Cash Flow (2014 - 2025)
KalVista Pharmaceuticals recorded quarterly Net Cash Flow of -$10.0 million in Q3 2025, up 74.3% quarter-over-quarter from -$39.0 million in Q2 2025, and down 17194.83% year-over-year from N/an in Q3 2024.
KalVista Pharmaceuticals' Net Cash Flow history runs 12 years deep, the most recent figure standing at -$10.0 million for Q3 2025.
- In Q3 2025, Net Cash Flow fell 17194.83% year-over-year to -$10.0 million; the TTM figure through Jul 2025 stood at -$39.7 million (down 142.59% YoY), while the FY2025 annual figure was $97.8 million, up 521.09% from the prior year.
- Net Cash Flow came in at -$10.0 million for Q3 2025 at KalVista Pharmaceuticals, up from -$39.0 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $46.0 million in Q1 2023 to a low of -$39.0 million in Q2 2025.
- A 5-year average of -$1.3 million and a median of -$359500.0 in 2022 frame the typical range for Net Cash Flow.
- Across the five-year window, Net Cash Flow soared 11866.5% in 2023 and tumbled 17194.83% in 2025, its largest moves.
- KalVista Pharmaceuticals' Net Cash Flow stood at -$1.8 million in 2021, then soared by 82.16% to -$328000.0 in 2022, then surged by 2800.91% to $8.9 million in 2023, then rose by 5.27% to $9.3 million in 2024, then slumped by 207.56% to -$10.0 million in 2025.
- According to Business Quant data, Net Cash Flow over the past three periods registered -$10.0 million, -$39.0 million, and $9.3 million for Q3 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 625.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 457.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -152.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 60.68 Mn |
| 10 | KalVista Pharmaceuticals | 1.44 Bn | 1.25 Bn | 56.41 Mn | -10.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | -10.03 Mn |
| Jul 31, 2025 | -10.03 Mn |
| Apr 30, 2025 | -39.03 Mn |
| Apr 30, 2025 | -39.03 Mn |
| Oct 31, 2024 | 9.33 Mn |
| Oct 31, 2024 | 9.33 Mn |
| Jul 31, 2024 | -58,000.00 |
| Jul 31, 2024 | -58,000.00 |
| Apr 30, 2024 | 8.81 Mn |
| Apr 30, 2024 | 8.81 Mn |
| Jan 31, 2024 | -33.99 Mn |
| Jan 31, 2024 | -33.99 Mn |
| Oct 31, 2023 | 8.86 Mn |
| Oct 31, 2023 | 8.86 Mn |
| Jul 31, 2023 | -6.91 Mn |
| Jul 31, 2023 | -6.91 Mn |
| Apr 30, 2023 | -28.88 Mn |
| Apr 30, 2023 | -28.88 Mn |
| Jan 31, 2023 | 46.01 Mn |
| Jan 31, 2023 | 46.01 Mn |
| Oct 31, 2022 | -328,000.00 |
| Oct 31, 2022 | -328,000.00 |
| Jul 31, 2022 | 7.47 Mn |
| Jul 31, 2022 | 7.47 Mn |
| Apr 30, 2022 | -14.22 Mn |
| Apr 30, 2022 | -14.22 Mn |
| Jan 31, 2022 | -391,000.00 |
| Jan 31, 2022 | -391,000.00 |
| Oct 31, 2021 | -1.84 Mn |
| Oct 31, 2021 | -1.84 Mn |
| Jul 31, 2021 | -2.25 Mn |
| Jul 31, 2021 | -2.25 Mn |
| Apr 30, 2021 | 32.78 Mn |
| Apr 30, 2021 | 32.78 Mn |
| Jan 31, 2021 | 1.06 Mn |
| Jan 31, 2021 | 1.06 Mn |
| Oct 31, 2020 | -1.52 Mn |
| Oct 31, 2020 | -1.52 Mn |
| Jul 31, 2020 | 1.97 Mn |
| Jul 31, 2020 | 1.97 Mn |
| Apr 30, 2020 | -2.59 Mn |
| Apr 30, 2020 | -2.59 Mn |
| Jan 31, 2020 | -3.29 Mn |
| Jan 31, 2020 | -3.29 Mn |
| Oct 31, 2019 | -9.19 Mn |
| Oct 31, 2019 | -9.19 Mn |
| Jul 31, 2019 | -1.41 Mn |
| Jul 31, 2019 | -1.41 Mn |
| Apr 30, 2019 | -24.40 Mn |
| Apr 30, 2019 | -24.40 Mn |
| Jan 31, 2019 | -65.39 Mn |
| Jan 31, 2019 | -65.39 Mn |
| Oct 31, 2018 | 73.78 Mn |
| Oct 31, 2018 | 73.78 Mn |
| Jul 31, 2018 | -1.83 Mn |
| Jul 31, 2018 | -1.83 Mn |
| Apr 30, 2018 | -7.05 Mn |
| Apr 30, 2018 | -7.05 Mn |
| Jan 31, 2018 | 27.99 Mn |
| Jan 31, 2018 | 27.99 Mn |
| Oct 31, 2017 | -7.31 Mn |
| Oct 31, 2017 | -7.31 Mn |
| Jul 31, 2017 | -4.56 Mn |
| Jul 31, 2017 | -4.56 Mn |
| Apr 30, 2017 | -2.65 Mn |
| Apr 30, 2017 | -2.65 Mn |
| Jan 31, 2017 | 22.89 Mn |
| Jan 31, 2017 | 22.89 Mn |
| Oct 31, 2016 | -4.20 Mn |
| Oct 31, 2016 | -4.20 Mn |
| Jul 31, 2016 | -5.70 Mn |
| Jul 31, 2016 | -5.70 Mn |
| Mar 31, 2016 | -5.27 Mn |
| Mar 31, 2016 | -5.27 Mn |
| Dec 31, 2015 | -6.16 Mn |
| Dec 31, 2015 | -6.16 Mn |
| Sep 30, 2015 | -5.50 Mn |
| Sep 30, 2015 | -5.50 Mn |
| Jun 30, 2015 | 62.20 Mn |
| Jun 30, 2015 | 62.20 Mn |
| Mar 31, 2015 | -716,000.00 |
| Mar 31, 2015 | -716,000.00 |
| Sep 30, 2014 | 2.15 Mn |
| Sep 30, 2014 | 2.15 Mn |
| Jun 30, 2014 | -2.10 Mn |
| Jun 30, 2014 | -2.10 Mn |
| Mar 31, 2014 | -505,000.00 |
| Mar 31, 2014 | -505,000.00 |